4//SEC Filing
DAmour Kevin 4
Accession 0001140361-22-009664
CIK 0000748592other
Filed
Mar 14, 8:00 PM ET
Accepted
Mar 15, 9:34 PM ET
Size
5.4 KB
Accession
0001140361-22-009664
Insider Transaction Report
Form 4
DAmour Kevin
See Remarks
Transactions
- Award
Stock Option (Right to buy)
2022-03-11+138,400→ 138,400 totalExercise: $1.93Exp: 2032-03-11→ Common Stock (138,400 underlying)
Footnotes (1)
- [F1]The options vest and become exercisable over three years, with 25% of the options vesting on the one-year anniversary of the grant date and the remaining options vesting in 24 substantially equal monthly installments thereafter.
Documents
Issuer
Brooklyn ImmunoTherapeutics, Inc.
CIK 0000748592
Entity typeother
Related Parties
1- filerCIK 0001870486
Filing Metadata
- Form type
- 4
- Filed
- Mar 14, 8:00 PM ET
- Accepted
- Mar 15, 9:34 PM ET
- Size
- 5.4 KB